This educational activity will provide an overview of nitrosamine impurities identified in several prescription and over-the-counter drug products. The presentation will include background information on nitrosamines, a discussion of pharmaceutical quality, FDA’s role in protecting the public, and an overview of public outreach and engagement as it relates to this issue.